Medicines Adaptive Pathways to Patients (MAPPs)

News & Events

The EFPIA view

EFPIA launches new resources on speeding up the development of, and access to, new medicines

27.01.15

Medicines Adaptive Pathways to Patients (MAPPs) are flexible development and access pathways within the current regulatory framework that balance early patient access, public health and societal benefits. Their aim? To find ways for patients to access new, innovative medicines more quickly. To find out more you can access the MAPPs section of the EFPIA website here.